- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Obinutuzumab
Total 278 results
-
BeiGeneCompletedB-cell Lymphoid MalignanciesAustralia, Korea, Republic of, United States
-
Arbeitsgemeinschaft medikamentoese TumortherapieRoche Pharma AGCompletedLymphoma, Large B-Cell, DiffuseAustria
-
Gilead SciencesGerman CLL Study GroupCompleted
-
Klinikum StuttgartUniversity Hospital FreiburgTerminatedPrimary CNS LymphomaGermany
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityCompletedRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
German CLL Study GroupHoffmann-La RocheTerminatedChronic Lymphocytic Leukemia | Richter's TransformationGermany
-
Gilead SciencesGerman CLL Study GroupCompleted
-
Hoffmann-La RocheTerminatedLymphoma, Large B-Cell, Diffuse | Follicular LymphomaUnited States, Australia, Germany, Korea, Republic of, New Zealand
-
Incyte CorporationCompletedLymphomaSpain, Hungary, United States, Denmark, Italy, Czechia
-
Ironwood Pharmaceuticals, Inc.Medpace, Inc.TerminatedGout | Chronic Kidney Disease (CKD)United States, Hungary, Poland, Czechia
-
CelgeneCompletedLeukemia, Lymphocytic, Chronic, B-CellSpain, United States, Italy, Germany, Austria
-
Stichting Hemato-Oncologie voor Volwassenen NederlandNordic Lymphoma GroupActive, not recruiting
-
Menarini GroupTerminatedTumor Lysis SyndromeSpain, Hungary, Italy, Bulgaria
-
Hoffmann-La RocheCompletedDiffuse Large B-Cell Lymphoma, Lymphoma FollicularUnited States, Australia, Italy
-
Aptevo TherapeuticsTerminatedChronic Lymphocytic Leukemia | Peripheral T-cell LymphomaUnited States
-
Ludwig-Maximilians - University of MunichHoffmann-La Roche; Janssen-Cilag G.m.b.HActive, not recruitingIndolent Non-Hodgkin LymphomaGermany
-
University Health Network, TorontoHoffmann-La Roche; Ozmosis Research Inc.CompletedLymphoma, Non-Hodgkin'sCanada
-
Hoffmann-La RocheTerminatedB-Cell Chronic Lymphocytic LeukemiaItaly, Spain, Israel, United Kingdom, Latvia
-
Grupo Cooperativo de Hemopatías MalignasCompletedB-Cell Chronic Lymphocytic Leukemia | B-Cell Chronic Lymphocytic Leukemia in Relapse (Diagnosis)Mexico
-
Hoffmann-La RocheCompletedLymphomaPoland, United States, Germany
-
Fondazione Italiana Linfomi ONLUSTerminatedCD20 Positive Diffuse Large B-cell Lymphoma | Elderly Unfit PatientsItaly
-
Genentech, Inc.AbbVie (prior sponsor, Abbott)CompletedChronic Lymphocytic LeukemiaUnited States, France, Germany
-
Pharmacyclics LLC.CompletedChronic Lymphocytic Leukemia | Small-Cell LymphomaUnited States, Australia, Austria, Belgium, Canada, Czechia, France, Israel, Italy, New Zealand, Poland, Russian Federation, Spain, Sweden, Turkey, United Kingdom
-
Hoffmann-La RocheTerminatedSolid TumorsSpain, Belgium, Denmark, Canada
-
Hoffmann-La RocheAbbVieCompletedLymphoma, Non-HodgkinSpain, Hungary, United States, Canada, Australia, Austria, Czechia, France, Italy, Netherlands
-
Hoffmann-La RocheTerminatedNon-Hodgkin's LymphomaUnited States, Australia, Korea, Republic of, Germany, New Zealand
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompletedChronic Lymphocytic LeukemiaArgentina
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Denmark, Spain, Canada, France, Netherlands, Italy
-
Nantes University HospitalRoche Pharma AG; Janssen, LPActive, not recruitingMantle Cell LymphomaFrance, United Kingdom
-
Genentech, Inc.CompletedFollicular Lymphoma | Diffuse Large B-Cell LymphomaUnited States, Canada, France, Italy, Germany, Netherlands
-
Genentech, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
Hoffmann-La RocheCompleted
-
Hoffmann-La RocheCompletedKidney Failure, ChronicUnited States
-
Hoffmann-La RocheCompletedLymphomaUnited States, France, Germany, Italy, United Kingdom
-
Genentech, Inc.Roche Pharma AGCompletedNon-Hodgkin's LymphomaUnited States, Spain, France, Canada, United Kingdom, Austria, Belgium, Czechia, Russian Federation, Italy, Switzerland, Germany, Netherlands, Sweden
-
Genentech, Inc.AbbVie (prior sponsor, Abbott)CompletedLymphocytic Leukemia, ChronicUnited States, United Kingdom
-
Hoffmann-La RocheCompletedChronic Lymphocytic LeukemiaItaly, Sweden, Belgium, Brazil, Canada, Germany, Ireland, Korea, Republic of, Spain, Russian Federation, France, Finland, Israel, Estonia, Romania, Egypt, Thailand, Switzerland, Bosnia and Herzegovina, Slovakia, Turkey, Lithuania, P... and more
-
TG Therapeutics, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaUnited States
-
Deok-Hwan YangRoche Pharma AGUnknown
-
Mỹ Đức HospitalCompletedPoor Ovarian ResponseVietnam
-
German CLL Study GroupHoffmann-La Roche; Janssen-Cilag Ltd.CompletedChronic Lymphocytic LeucemiaGermany
-
Hoffmann-La RocheFondazione Italiana Linfomi ONLUSTerminatedDiffuse Large B-Cell LymphomaItaly, China, Korea, Republic of, Canada, Australia, United States, Austria, Brazil, Denmark, Panama, Peru, Spain, Colombia, United Kingdom, Switzerland, Thailand, Mexico, Taiwan, Hong Kong, Russian Federation, Hungary, Japan, Germany, South Africa and more
-
French Innovative Leukemia OrganisationRoche Pharma AG; Janssen-Cilag Ltd.Completed
-
Michael ChoiPharmacyclics LLC.Withdrawn
-
Gilead SciencesTerminatedChronic Lymphocytic LeukemiaUnited States, France, Spain, Poland, United Kingdom, Australia, Belgium, Canada
-
Polish Myeloma ConsortiumRoche Pharma AG; Bioscience, S.A.UnknownWaldenstrom MacroglobulinemiaPoland
-
Hoffmann-La RocheGenentech, Inc.; German CLL Study GroupCompletedLymphocytic Leukemia, ChronicAustralia, France, Germany, Italy, Spain, Hong Kong, Canada, Switzerland, Estonia, Mexico, New Zealand, Denmark, Russian Federation, United States, Austria, Bulgaria, Czechia, United Kingdom, Thailand, Romania, Croatia, Brazil, Arge... and more
-
Hoffmann-La RocheGenentech, Inc.; German CLL Study GroupCompletedLymphocytic Leukemia, ChronicAustralia, France, Germany, Spain, Hong Kong, Canada, Switzerland, Estonia, Mexico, New Zealand, Denmark, Russian Federation, United States, Austria, Bulgaria, Czechia, United Kingdom, Italy, Thailand, Romania, Croatia, Brazil, Arge... and more